Analysed ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) News Sources
ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
31-03-2026
yahoo.com
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
10-09-2025
yahoo.com
ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression
03-09-2025
yahoo.com
ZyVersa Therapeutics Highlights Data Demonstrating a Critical Need for Therapies to Address Kidney Lipotoxicity to Alleviate Diabetic Kidney Disease (DKD) and Its Progression
14-08-2025
yahoo.com
ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones
13-08-2025
yahoo.com
ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress
21-07-2025
yahoo.com
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds
08-07-2025
yahoo.com
What is the current price of ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS)?
The current price of ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) is $0.22.
ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) since the previous trading day is $0.0004.
ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) since the previous trading day is 0.1821%.
What is the most recent average sentiment score for ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS)?
The most recent average sentiment score for ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS)?
The most recent sentiment for ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS) is .
SEC-8K** Filing Available For ZYVERSA THERAPEUTICS INC (ZVSA:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.